Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Frontiers in ImmunologyOpen Access

FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy

View Full Paper
Ask AI
Bookmark
Share

Authors

QZQian ZhengJZJiajie ZhangHSHong‐Shu Sui

Discussion

Loading...

Member takes

Implication

Comparative analysis shows FLT3L plus GM-CSF improves dendritic cell attributes and anti-tumor responses, indicating potential for enhanced immunotherapy.

Key Points

  • FL/GM-DCs induced a broader tumor-specific CD8+ T cell response, enhancing anti-tumor efficacy.
  • Analysis revealed FL/GM-DCs displayed a unique subpopulation distribution, improving cross-antigen presentation.
  • In vivo experiments confirmed FL/GM-DCs reshaped the tumor microenvironment, increasing cytotoxic T lymphocyte infiltration.
  • Compared to GM/IL4-DCs, FL/GM-DCs achieved superior immunotherapy outcomes through their unique composition and function.

Cite This Study

Zheng et al. (2025) studied this question.

synapsesocial.com/papers/68c23c20b210217d647875f2https://doi.org/10.3389/fimmu.2025.1649891
View Full Paper
Ask AI
Bookmark
Share